Our comprehensive study of glutamine transporters expression levels in HCC as well as their respective involvement in patient overall prognosis identified SLC1A5 as being an upregulated glutamine transporter specifically in aggressive HCC tumor subtypes. The gene discussed is SLC1A5; the disease is neoplasm.